QSP Newsletter

QSP Newsletter 37 - Hemoglobinopathies (Part 2)

July 2023

Monthly Digital Case Study
June 2023 QSP Slides
Hemoglobinopathies - Part 2
Quiz
(PDF for print)

Monthly Digital Case Study

 

June 2023 QSP Slide 5:

QSP Newsletter 37 Case - Study Slide 5 Image 1
QSP Newsletter 37 Case - Study Slide 5 Image 2

FBC Results

WBC6.35 (10^3/mm3)Neutrophils53%
RBC3.41* (10^6/mm3)Lymphocytes19.9%
HGB14.2* (g/dL)Monocytes21.3%
HCT30.7* (%)Eosinophils5.1%
MCV90 (fL)Basophils0%
MCH41.6 (pg)  
MCHC46.3 (g/dL)  
PLT363 (10^3/mm3)  

Clinical Details

05 June 2023, Male (64 years old)

Slide Information

Red blood cell flags. Agglutination of red blood cells (+++) due to the presence of a cold agglutinin verified after incubation of the sample at 37°C and rerun of this sample to check the results associated with the parameters which were alarmed.

Expert Comment: 

Look for a cold agglutinin. Cold agglutinin disease/lymphoproliferative syndrome?

June 2023 QSP Slides

► Nothing to report.

► Hyperlymphocytosis associated with numerous smudge which may be compatible with lymphoproliferative syndrome or non-Hodgkin's lymphoma. Request immunophenotyping of circulating lymphocytes with establishment of a Matutes scoring and a cytogenetic assessment. Note: Presence of incised nuclei on numerous images of lymphocytes. 

► Microcytes (+). Anisocytosis (+). Schizocytes (+). Echinocytes (+). Hypochromia (++).

Expert's comments: suspected iron deficiency.

► Macrocytic anisocytosis (+). Spherocytes (+). Discreet myelemia.

Expert's comments: Exclude a chronic monocytic myeloid leukemia.

► See monthly case study above.

► Anemia. Anisocytosis (+++). Microcytes (+++). Macrocyte (+++). Spherocytes (++). Polychromatophilic (++) RBCs. Presence of punctuated RBCs and some acidophilic erythroblasts. Reticulocytosis (+++): 18% Reticulocytes (RET#: 306x10^9/L). 

Expert's comment: Autoimmune hemolytic anemia? (Presence of spherocytes)

Hemoglobinopathies - Part 2

The most significant hemoglobinopathies result in either a change in the structure and quality of the hemoglobin, or a reduction in the quantity of hemoglobin produced.

Hemoglobinopathies are:

• not gender (x) linked
• more prevalent in some parts of the world

The likelihood of a person being a carrier of a hemoglobinopathy depends on ancestry. The type of mutation varies between ethnic groups. It is possible to inherit mutations in both alpha and beta globin genes at the same time. It is also possible (although rare) for an individual to have a ‘de novo’ hemoglobin mutation. This is a genetic mutation that is not directly inherited from parents but is present only in that individual.

 

Inheritance

The genes to produce hemoglobin are inherited from both parents. Sickle cell disease or beta thalassemia major are recessively inherited. If one unusual beta chain gene is inherited from one parent, the individual will be a carrier of the condition but will not be affected. This is known as having a trait. Carriers of hemoglobin variants are healthy and are unaware of their status unless detected during screening.

Should two unusual beta chain genes are inherited (one from each parent), the individual will have a hemoglobin disorder. The most common clinically significant conditions are beta thalassemia major and sickle cell disease.

If both parents carry a significant hemoglobinopathy, the baby is at risk of inheriting a hemoglobin disorder. There is a:

• 1 in 4 (25%) chance of being completely unaffected
• 2 in 4 (50%) chance of being a carrier
• 1 in 4 (25%) chance of inheriting the condition:

QSP_Newsletter_37_Hemoglobinopathies_Inheritance

Sickle Disease

Sickle carrier

If a person  inherited one normal haemoglobin A gene and one sickle haemoglobin gene, they are a sickle carrier. With one typical haemoglobin gene and one altered form of the gene, people with the sickle cell trait make both typical haemoglobin and sickle cell haemoglobin.

Their blood might contain some sickle cells, but they generally don't have symptoms. They're carriers of the disease, however, which means they would pass the gene to their children.

 

Sickle cell disease

Sickle cell disease occurs when a person inherits two abnormal copies of the β-globin gene (HBB) that makes hemoglobin, one from each parent. This gene occurs in chromosome 11. Several subtypes exist, depending on the exact mutation in each hemoglobin gene.

Sickle cell disease most commonly affects people of West African, Caribbean, Middle Eastern and Indian ancestry. However, it can affect anyone from any population.

Sickle rbc’s have a shorter than average life span (10-20 days), and this premature destruction results in anemia. Unlike normal rbc’s which are flexible, sickle cells are rigid and also sticky. This can cause clumping in vessel walls, resulting in obstruction and a reduced oxygen supply to various organs. This occurs frequently and manifests itself as periodic  episodes of pain, known as “crisis”. These Vaso-occlusive events can result in damage to eyes, kidneys, and lungs.

Normal red blood cells

Normal red blood cells

Sickle red blood cells

Sickle red blood cells

As the spleen is managing increased numbers of dead rbc’s, it becomes fibrous and enlarged. The immune function in the spleen declines, which results in the individual being more susceptible to infection. The hyposplenism would be indicated by the presence of Howell-Jolly bodies and target cells. In an attempt to compensate for the rbc loss, the bone marrow attempts to produce more cells and grow larger. This results in weakened bones. Patients also present with jaundice due to the rapid destruction of heme in the rbc’s.

 

Treatment

  • Bone marrow transplant is currently the only known cure (replacing diseased stem cells with healthy donor cells.
  • Prophylactic antibiotics treatment to avoid crisis and relieve symptoms
  • Drugs to promote formation of foetal haemoglobin to suppress sickling
  • Periodic blood transfusions to prevent anaemia and prevent crisis

QSP Newsletter 37 Quiz Cell Image

Cell Quiz

Name the white cell in the slide image.

A) Blast cell
B) Eosinophil
C) Basophil

The answer will be displayed in the next QSP Newsletter and on our social media (LinkedIn / Facebook / Twitter).

Last Month’s Quiz Answer

What feature can be seen in the red cell?

A) Basophilic Stippling
B) Bitten Out Cell
C) Cabot’s Ring

The Answer:

Basophilic Stippling or punctate basophilia describes the presence of numerous small basophilic inclusions in the cytoplasm of the red cell. They are composed of aggregates of ribosomes, degenerating mitochondria and siderosomes. Basophilic Stippling is associated with conditions such as thalassemia, hemolytic anemia, myelodysplastic syndromes, sickle cell anemia, heavy metal poisoning (lead, zinc, arsenic, etc.)

Quality Slide Program (QSP) 2.0

Available as a single use license and a site license which allows up to 50 concurrent users.

Subscribe_to_QSP_Newsletter

Subscribe to QSP newsletter

Subscribe to our monthly QSP Newsletter to see detailed morphology case studies, disease focuses, morphology tips, slide reviews, and quizzes!

HORIBA_Medical_QSP_Newsletter_Image

Back issues

All the QSP Newsletters published before are available here.

Pedido de Informação

Você tem alguma dúvida ou solicitação? Utilize este formulário para entrar em contato com nossos especialistas.

* Esses campos são obrigatórios.

Corporate